Condition
Neoplasms, Glandular and Epithelial clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Neoplasms, Glandular and Epithelial clinical trials that are recruiting, at sites in 3 countries (most in United States (2), Israel (1), China (1)). By phase: Phase 2 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 3Countries
Newest Neoplasms, Glandular and Epithelial clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| TriAdeno and N-803 vaccine in early prostate cancer on active surveillance | Phase 2 | Bethesda, Maryland | Recruiting | May 8, 2026 |
| Multimodal ablation with Tislelizumab, lenvatinib and TACE for unresectable primary liver cancer | — | Shanghai, Shanghai Municipality | Recruiting | Jan 27, 2025 |
| Combination of Pembrolizumab and Lenvatinib for Ovarian Cancer | Phase 2 | Ramat Gan | Recruiting | Aug 19, 2020 |
| Using a virus therapy to treat recurrent cerebellar brain tumors in children | Phase 1 | Birmingham, Alabama and 2 other locations | Recruiting | Apr 11, 2019 |
All recruiting trials (4)
-
TriAdeno and N-803 vaccine in early prostate cancer on active surveillance
A vaccine combo called TriAdeno plus the N-803 drug is being tested to see if it can help slow or stop growth in men with early-stage, low- to intermediate-risk prostate cancer who are being watched rather than treated right away.
-
Multimodal ablation with Tislelizumab, lenvatinib and TACE for unresectable primary liver cancer
This trial will test whether combining multimodal ablation with Tislelizumab (a PD‑1 antibody), lenvatinib, and TACE helps people with unresectable primary liver cancer.
-
Combination of Pembrolizumab and Lenvatinib for Ovarian Cancer
This study is testing a combination of two medications, pembrolizumab and lenvatinib, to see if they can help women with recurrent ovarian cancer that is sensitive to platinum-based treatments.
-
Using a virus therapy to treat recurrent cerebellar brain tumors in children
This study is testing a new virus treatment for children with recurring brain tumors to see if it can help them get better when combined with a low dose of radiation.
Related topics
Quick answers
How many Neoplasms, Glandular and Epithelial clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (2 trials), Israel (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.